Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Brain Inflammation Connects Cognitive and Non-Cognitive Symptoms in Alzheimer’s Disease
María Clara Sellés, Maurício M. Oliveira, Sérgio T. Ferreira
Journal of Alzheimer s Disease (2018) Vol. 64, Iss. s1, pp. S313-S327
Closed Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Anesthesiology and cognitive impairment: a narrative review of current clinical literature
Jillian C. Belrose, Ruediger Noppens
BMC Anesthesiology (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 165
Inflammation context in Alzheimer’s disease, a relationship intricate to define
Catalina Novoa, Paulina Salazar, Pedro Cisternas, et al.
Biological Research (2022) Vol. 55, Iss. 1
Open Access | Times Cited: 95
Inflammation at the crossroads of COVID-19, cognitive deficits and depression
Natalia M. Lyra e Silva, Fernanda G. Q. Barros‐Aragão, Fernanda G. De Felice, et al.
Neuropharmacology (2022) Vol. 209, pp. 109023-109023
Open Access | Times Cited: 79
Role of Neuroinflammation in Autism Spectrum Disorder and the Emergence of Brain Histaminergic System. Lessons Also for BPSD?
Nermin Eissa, Adel Sadeq, Astrid Sasse, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 76
Ultrastructural characterization of dark microglia during aging in a mouse model of Alzheimer’s disease pathology and in human post-mortem brain samples
Marie‐Kim St‐Pierre, Micaël Carrier, Fernando González Ibáñez, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 47
Brain insulin, insulin‐like growth factor 1 and glucagon‐like peptide 1 signalling in Alzheimer’s disease
Sérgio T. Ferreira
Journal of Neuroendocrinology (2021) Vol. 33, Iss. 4
Closed Access | Times Cited: 47
p-Coumaric acid ameliorates cognitive and non-cognitive disturbances in a rat model of Alzheimer’s disease: The role of oxidative stress and inflammation
Shahab Ghaderi, Parsa Gholipour, Alireza Komaki‬, et al.
International Immunopharmacology (2022) Vol. 112, pp. 109295-109295
Closed Access | Times Cited: 36
Brain FNDC5/Irisin Expression in Patients and Mouse Models of Major Depression
Ricardo A. S. Lima-Filho, Juliana S. Fortuna, Danielle Cozachenco, et al.
eNeuro (2023) Vol. 10, Iss. 2, pp. ENEURO.0256-22.2023
Open Access | Times Cited: 20
Cerebrospinal fluid: A specific biofluid for the biosensing of Alzheimer's diseases biomarkers
Arezoo Mirzaie, Hassan Nasrollahpour, Balal Khalilzadeh, et al.
TrAC Trends in Analytical Chemistry (2023) Vol. 166, pp. 117174-117174
Closed Access | Times Cited: 17
Association of anxiety with subcortical amyloidosis in cognitively normal older adults
Bernard Hanseeuw, Victoria Jonas, Jonathan Jackson, et al.
Molecular Psychiatry (2018) Vol. 25, Iss. 10, pp. 2599-2607
Open Access | Times Cited: 47
Effects of compound K, a metabolite of ginsenosides, on memory and cognitive dysfunction in db/db mice involve the inhibition of ER stress and the NLRP3 inflammasome pathway
Chuwen Li, Minzhen Deng, Zhijie Gao, et al.
Food & Function (2020) Vol. 11, Iss. 5, pp. 4416-4427
Closed Access | Times Cited: 45
Pharmacological enhancement of cholinergic neurotransmission alleviates neuroinflammation and improves functional outcomes in a triple transgenic mouse model of Alzheimer’s disease
Antonio Munafò, Anna Cantone, Giulia Di Benedetto, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Choline Supplementation Ameliorates Behavioral Deficits and Alzheimer's Disease‐Like Pathology in Transgenic APP/PS1 Mice
Yanyan Wang, Xingying Guan, Xuedan Chen, et al.
Molecular Nutrition & Food Research (2019) Vol. 63, Iss. 18
Closed Access | Times Cited: 42
Cerebrospinal Fluid Correlates of Neuropsychiatric Symptoms in Patients with Alzheimer’s Disease/Mild Cognitive Impairment: A Systematic Review
Alireza Showraki, Geetanjali Murari, Zahinoor Ismail, et al.
Journal of Alzheimer s Disease (2019) Vol. 71, Iss. 2, pp. 477-501
Closed Access | Times Cited: 42
Neferine alleviates memory and cognitive dysfunction in diabetic mice through modulation of the NLRP3 inflammasome pathway and alleviation of endoplasmic-reticulum stress
Xiaoli Wu, Minzhen Deng, Zhijie Gao, et al.
International Immunopharmacology (2020) Vol. 84, pp. 106559-106559
Closed Access | Times Cited: 39
Hepatoprotective effect of chlorogenic acid against chronic liver injury in inflammatory rats
Zhenlong Chen, Yuhui Yang, Shumei Mi, et al.
Journal of Functional Foods (2019) Vol. 62, pp. 103540-103540
Closed Access | Times Cited: 38
RNA Sequencing Reveals Small and Variable Contributions of Infectious Agents to Transcriptomes of Postmortem Nervous Tissues From Amyotrophic Lateral Sclerosis, Alzheimer’s Disease and Parkinson’s Disease Subjects, and Increased Expression of Genes From Disease-Activated Microglia
James P. Bennett, Paula M. Keeney, David G. Brohawn
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 36
Nutrition in Alzheimer’s disease: a review of an underappreciated pathophysiological mechanism
Jiwei Jiang, Hanping Shi, Shirui Jiang, et al.
Science China Life Sciences (2023) Vol. 66, Iss. 10, pp. 2257-2279
Open Access | Times Cited: 11
Monomeric C-Reactive Protein Localized in the Cerebral Tissue of Damaged Vascular Brain Regions Is Associated With Neuro-Inflammation and Neurodegeneration-An Immunohistochemical Study
Raid Saleem Al-Baradie, Shuang Pu, Donghui Liu, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 24
Peripheral Inflammation and Insulin Resistance: Their Impact on Blood–Brain Barrier Integrity and Glia Activation in Alzheimer’s Disease
Teresa Ponce-López
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 9, pp. 4209-4209
Open Access
Obesity and Alzheimer's disease dementia: Examining inflammatory links to cognitive decline and neuropsychiatric symptoms
Carolin Koriath, Robert Perneczky
Journal of Alzheimer s Disease (2025)
Closed Access
Dysautonomia in Alzheimer’s Disease: A Systematic Review
Μarianna Papadopoulou, Maria‐Ioanna Stefanou, Eleni Bakola, et al.
Brain Sciences (2025) Vol. 15, Iss. 5, pp. 502-502
Open Access
Cerebrospinal Fluid Neurotransmitters, Cytokines, and Chemokines in Alzheimer’s and Lewy Body Diseases
Mychael V. Lourenco, Felipe C. Ribeiro, Luís E. Santos, et al.
Journal of Alzheimer s Disease (2021) Vol. 82, Iss. 3, pp. 1067-1074
Closed Access | Times Cited: 21
Purinergic signaling in cognitive impairment and neuropsychiatric symptoms of Alzheimer's disease
Deidiane Elisa Ribeiro, Lyvia Lintzmaier Petiz, Talita Glaser, et al.
Neuropharmacology (2022) Vol. 226, pp. 109371-109371
Closed Access | Times Cited: 14
Identifying Blood Transcriptome Biomarkers of Alzheimer’s Disease Using Transgenic Mice
Shinichiro Ochi, Jun‐ichi Iga, Yu Funahashi, et al.
Molecular Neurobiology (2020) Vol. 57, Iss. 12, pp. 4941-4951
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top